𝛼SK or Searchbullish
Hone Health At $114M ARR Growing 82% YoY
222 Views19 Oct 2025 08:00
TL;DR: After launching a women's line in January 2025 and expanding into weight loss (GLP-1s) and longevity (metformin & glutathione), Sacra estimates Hone Health hit $113.5M in annual recurring revenue (ARR) in September 2025, up 82% YoY and up from $69.7M at the end of 2024, with monthly growth doubling from ~3% to ~6%. For more, check out our full report and dataset...
What is covered in the Full Insight:
- Introduction to Hone Health
- Financial Performance and Growth
- Competitive Landscape
- Expansion into New Segments
- Conclusion and Future Outlook
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Hone Health At $114M ARR Growing 82% YoY19 Oct 2025
x